Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents

被引:6
|
作者
Boraey, Naglaa F. [1 ]
Bebars, Marwa A. [2 ]
Wahba, Ali A. [3 ]
Abd El Lateef, Hanan M. [4 ]
Attia, Mohamed Atif [5 ]
Elsayed, Ahmed H. [6 ]
Rashed, Khalid A. [6 ]
Sorour, Ehab I. [6 ]
Ahmed, Mohamed F. [6 ]
Abd-Elrehim, Ghada A. B. [1 ]
Soliman, Attia A. [7 ]
Shehab, Mohamed M. M. [7 ]
Elhindawy, Eman M. [7 ]
Ibraheem, Ahmed A. A. [7 ]
Shehata, Hassan [7 ]
Yousif, Yousif M. [7 ]
Hashem, Mustafa I. A. [7 ]
Ahmed, Amani A. [7 ]
Emam, Ahmed A. [7 ]
Gameil, Dalia M. [7 ]
Abdelhady, Eman M. [7 ]
Abdelkhalek, Khalil [8 ]
Morsi, Walaa E. M. A. [8 ]
Selim, Dalia M. [4 ]
Razek, Suzan A. [4 ]
Ashraf, Bassem [9 ]
Saleh, Ahmed S. E. [10 ]
Eltrawy, Heba H. [11 ]
Alanwar, Mohamed I. [12 ]
Fouad, Rania A. [13 ,14 ]
Omar, Walaa E. [14 ]
Nabil, Rehab M. [15 ]
Abdelhamed, Mohamed R. [16 ]
Ibrahim, Mona Yousri [17 ]
Malek, Mai M. [18 ]
Afify, Mona R. [19 ]
Alharbi, Mohanned T. [19 ]
Nagshabandi, Mohammed K. [19 ]
Tarabulsi, Muyassar K. [19 ]
Qashqary, Mohammed Esmail [20 ]
Almoraie, Laila M. [20 ]
Salem, Hanan F. [21 ]
Rashad, Manal M. [22 ]
El-Gaaly, Sonya A. A. [23 ]
El-Deeb, Nahawand A. [24 ]
Abdallah, Amany M. [25 ]
Fakhreldin, Ahmed R. [26 ]
Hassouba, Mohamed [27 ]
Massoud, Yasmine M. [28 ]
Attaya, Mona S. M. [29 ]
机构
[1] Sohag Univ, Fac Med, Dept Pediat, Sohag, Egypt
[2] Princess Alexandra Hosp, Dept Pediat, Harlow, England
[3] SSMC Sheikh Shakhbout Med City, Dept Pediat, Abu Dhabi, U Arab Emirates
[4] Ain Shams Univ, Fac Med, Dept Pediat, Cairo, Egypt
[5] SKMC Sheikh Khalifa Med City, Dept Pediat, Abu Dhabi, U Arab Emirates
[6] Al Azhar Univ, Fac Med Boys, Dept Pediat, Al Azhar, Egypt
[7] Zagazig Univ, Fac Med, Dept Pediat, Zagazig, Egypt
[8] Cairo Univ, Fac Med, Dept Pediat, Cairo, Egypt
[9] Mansoura Univ, Fac Med, Dept Otorhinolaryngol, Mansoura, Egypt
[10] Benha Univ, Fac Med, Dept Otorhinolaryngol, Banha, Egypt
[11] Al Azhar Univ, Fac Med Girls, Dept Chest Dis, Al Azhar, Egypt
[12] Zagazig Univ, Fac Med, Dept Cardiothorac Surg, Zagazig, Egypt
[13] AlMaarefa Univ, Coll Med, Dept Med Biochem, Riyadh, Saudi Arabia
[14] Zagazig Univ, Fac Med, Dept Med Biochem, Zagazig, Egypt
[15] Zagazig Univ, Fac Med, Dept Clin Pathol, Zagazig, Egypt
[16] Al Azhar Univ, Fac Med Boys, Dept Clin Pathol, Al Azhar, Egypt
[17] Al Azhar Univ, Fac Med Girls, Dept Clin Pathol, Al Azhar, Egypt
[18] Zagazig Univ, Fac Med, Dept Microbiol & Immunol, Zagazig, Egypt
[19] Univ Jeddah, Fac Med, Dept Med Microbiol & Parasitol, Jeddah 21589, Saudi Arabia
[20] Univ Jeddah, Univ Med Ctr, Dept Family & Community Med, Jeddah, Saudi Arabia
[21] Benha Univ, Fac Med, Dept Anesthesia, Banha, Egypt
[22] Zagazig Univ, Fac Med, Dept Anesthesia, Zagazig, Egypt
[23] Ain Shams Univ, Fac Med, Dept Internal Med, Ain Shams, Egypt
[24] Zagazig Univ, Fac Med, Dept Internal Med, Zagazig, Egypt
[25] Zagazig Univ, Fac Med, Dept Family Med, Zagazig, Egypt
[26] Aswan Univ, Fac Med, Dept Pediat, Aswan, Egypt
[27] SUNY Downstate Hlth Sci Univ, Kings Cty Hosp, Dept Pediat, Brooklyn, NY USA
[28] Ain Shams Univ, Fac Med, Dept Trop Med, Ain Shams, Egypt
[29] Al Azhar Univ, Fac Med Girls, Dept Pediat, Al Azhar, Egypt
[30] Assiut Univ, Fac Med, Dept Pediat, Assiut, Egypt
关键词
CONVERTING-ENZYME GENE; INSERTION/DELETION POLYMORPHISM; ANGIOTENSIN; GENOTYPE; DISEASE;
D O I
10.1038/s41390-023-02982-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Given the sparse data on the renin-angiotensin system (RAS) and its biological effector molecules ACE1 and ACE2 in pediatric COVID-19 cases, we investigated whether the ACE1 insertion/deletion (I/D) polymorphism could be a genetic marker for susceptibility to COVID-19 in Egyptian children and adolescents.Methods: This was a case-control study included four hundred sixty patients diagnosed with COVID-19, and 460 well-matched healthy control children and adolescents. The I/D polymorphism (rs1799752) in the ACE1 gene was genotyped by polymerase chain reaction (PCR), meanwhile the ACE serum concentrations were assessed by ELISA.Results: The ACE1 D/D genotype and Deletion allele were significantly more represented in patients with COVID-19 compared to the control group (55% vs. 28%; OR = 2.4; [95% CI: 1.46-3.95]; for the DD genotype; P = 0.002) and (68% vs. 52.5%; OR: 1.93; [95% CI: 1.49-2.5] for the D allele; P = 0.032). The presence of ACE1 D/D genotype was an independent risk factor for severe COVID-19 among studied patients (adjusted OR: 2.6; [95% CI: 1.6-9.7]; P < 0.001.Conclusions: The ACE1 insertion/deletion polymorphism may confer susceptibility to SARS-CoV-2 infection in Egyptian children and adolescents.
引用
收藏
页码:1347 / 1354
页数:8
相关论文
共 50 条
  • [1] COVID-19 infections are also affected by human ACE1 D/I polymorphism
    Delanghe, Joris R.
    Speeckaert, Marijn M.
    De Buyzere, Marc L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1125 - 1126
  • [2] Role of ACE1 gene polymorphism in the development of COVID-19
    Belyaeva, Svetlana V.
    Vavilov, Mikhail N.
    Evdokimov, Alexander V.
    Kofiadi, Ilya A.
    Suslova, Tatiana A.
    HLA, 2022, 99 (05) : 530 - 530
  • [3] Role of I/D polymorphism in ACE1 gene associated with the COVID-19 severity in young women, but not in children from Ukraine
    Harashchenko, Tetiana
    Krasnienkov, Dmytro
    Gorodna, Oleksandra
    Mohylevets, Anastasiia
    Kaminska, Tetiana
    Podolskiy, Vasiliy
    Umanets, Tetiana
    Antipkin, Yuriy
    Livshits, Ludmila
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1181 - 1182
  • [4] Association of the rs4646994 Polymorphism in the ACE1 Gene with the Severity of COVID-19 in Children from Ukraine
    Harashchenko, T. A.
    Umanets, T. R.
    Mohylevets, A. O.
    Gorodna, O. V.
    Krasnienkov, D. S.
    Antypkin, Yu. G.
    Livshits, L. A.
    CYTOLOGY AND GENETICS, 2025, 59 (01) : 47 - 53
  • [5] Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients
    Verma, Sushma
    Abbas, Mohammad
    Verma, Shrikant
    Khan, Faizan Haider
    Raza, Syed Tasleem
    Siddiqi, Zeba
    Ahmad, Israr
    Mahdi, Farzana
    INFECTION GENETICS AND EVOLUTION, 2021, 91
  • [6] The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study
    Faridzadeh, Arezoo
    Mahmoudi, Mahmoud
    Ghaffarpour, Sara
    Zamani, Mohammad Saber
    Hoseinzadeh, Akram
    Naghizadeh, Mohammad Mehdi
    Ghazanfari, Tooba
    FRONTIERS IN GENETICS, 2022, 13
  • [7] The first assessment of Angiotensin-Converting Enzyme 1 (ACE1) D/I polymorphism and demographic factors in association with COVID-19 outcomes in the Moroccan Population
    El Bouchikhi, Ihssane
    El Otmani, Ihsane
    Ahakoud, Mohamed
    Kettani, Oussama
    El Makhzen, Badreddine
    Yahyaoui, Ghita
    Oumokhtar, Bouchra
    Ouldim, Karim
    El-Azami-El-Idrissi, Mohammed
    Achour, Sanae
    Mahmoud, Mustapha
    Bouguenouch, Laila
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [8] Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
    Akbari, Mohammadarian
    Taheri, Mohammad
    Mehrpoor, Golbarg
    Eslami, Solat
    Hussen, Bashdar Mahmud
    Ghafouri-Fard, Soudeh
    Arefian, Noormohammad
    VASCULAR PHARMACOLOGY, 2022, 142
  • [9] Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease
    Mojtaba Najafi
    Mohammad Reza Mahdavi
    Molecular Genetics and Genomics, 2023, 298 : 27 - 36
  • [10] Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease
    Najafi, Mojtaba
    Mahdavi, Mohammad Reza
    MOLECULAR GENETICS AND GENOMICS, 2023, 298 (01) : 27 - 36